Corient Private Wealth LLC Makes New Investment in Nu Skin Enterprises, Inc. (NYSE:NUS)

Corient Private Wealth LLC bought a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) during the fourth quarter, Holdings Channel.com reports. The fund bought 18,562 shares of the company’s stock, valued at approximately $128,000.

Several other institutional investors and hedge funds have also recently modified their holdings of NUS. Weiss Asset Management LP acquired a new position in Nu Skin Enterprises during the third quarter worth $2,727,000. Centiva Capital LP purchased a new stake in shares of Nu Skin Enterprises during the third quarter worth about $508,000. Verition Fund Management LLC purchased a new stake in shares of Nu Skin Enterprises during the third quarter worth about $581,000. JPMorgan Chase & Co. raised its position in shares of Nu Skin Enterprises by 175.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company’s stock worth $1,710,000 after purchasing an additional 147,784 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC lifted its stake in Nu Skin Enterprises by 27.7% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 603,555 shares of the company’s stock valued at $4,448,000 after buying an additional 130,980 shares in the last quarter. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Price Performance

Nu Skin Enterprises stock opened at $7.15 on Thursday. The company’s 50 day moving average is $7.37 and its two-hundred day moving average is $7.08. The firm has a market cap of $355.52 million, a PE ratio of -2.42 and a beta of 1.06. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. Nu Skin Enterprises, Inc. has a 52-week low of $5.95 and a 52-week high of $14.00.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The company had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. On average, research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th were given a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.36%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently -8.14%.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, February 25th. DA Davidson decreased their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, December 20th.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.